Label Image (Lbl500905730)
Ramipril Capsule
Product Images NDC 50090-5730
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 50090-5730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Ramipril Fig1)
This appears to be a graph or chart showing the proportion of patients taking the medication Ramipril over days of follow-up. The numbers on the vertical axis show the proportions ranging from 0 to 0.2. There is a significant decrease in the proportion of patients taking Ramipril over time, with a P-value of 0.0001 indicating statistical significance. The text may not be complete, but this is the information obtained from it.*
Figure 2 (Ramipril Fig2)
This appears to be the tabulated results from a medical trial. It includes data on the incidence of cardiovascular disease, diabetes, hypertension, coronary artery disease, cerebrovascular disease, peripheral vascular disease in both male and female groups, among others. Additionally, it includes the number of patients and incidence of composite outcomes in a placebo group. However, without context or an explanation of the trial's objective, the results are not useful for interpretation.*
Chemical Structure (Ramipril Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
